| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |